In the last trading session, 1.98 million Gossamer Bio Inc (NASDAQ:GOSS) shares changed hands as the company’s beta touched 1.87. With the company’s per share price at $1.23 changed hands at -$0.02 or -1.60% during last session, the market valuation stood at $279.58M. GOSS’s last price was a discount, traded about -26.02% off its 52-week high of $1.55. The share price had its 52-week low at $0.66, which suggests the last value was 46.34% up since then. When we look at Gossamer Bio Inc’s average trading volume, we note the 10-day average is 3.94 million shares, with the 3-month average coming to 1.92 million.
Analysts gave the Gossamer Bio Inc (GOSS) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.44. If we narrow down to specifics, the data shows that 0 out of 10 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 3 recommended GOSS as a Hold, 7 felt it is a Buy and 0 rated the stock as Underweight.
Gossamer Bio Inc (NASDAQ:GOSS) trade information
Instantly GOSS was in red as seen at the end of in last trading. With action -10.22%, the performance over the past five days has been red. The company’s shares are showing year-to-date upside of 30.95%, with the 5-day performance at -10.22% in the red. However, in the 30-day time frame, Gossamer Bio Inc (NASDAQ:GOSS) is 8.85% up. Looking at the short shares, we see there were 11.08 million shares sold at short interest cover period of 7.56 days.
The consensus price target for the stock as assigned by Wall Street analysts is 4, meaning bulls need an upside of 69.25% from its current market value. According to analyst projections, GOSS’s forecast low is 2 with 5 as the target high. To hit the forecast high, the stock’s price needs a -306.5% plunge from its current level, while the stock would need to soar -62.6% for it to hit the projected low.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 40.29%. The 2025 estimates are for Gossamer Bio Inc earnings to decrease by -168.69%, but the outlook for the next 5-year period is at 15.97% per year.
GOSS Dividends
Gossamer Bio Inc is expected to release its next quarterly earnings report on 2025-May-15.
Gossamer Bio Inc (NASDAQ:GOSS)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 3.51% of Gossamer Bio Inc shares while 75.98% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 78.74%. There are 75.98% institutions holding the Gossamer Bio Inc stock share, with NEA MANAGEMENT COMPANY, LLC the top institutional holder. As of 2024-06-30, the company held 7.9979% of the shares, roughly 18.09 million GOSS shares worth $16.3 million.
ARTAL GROUP S.A. holds the second largest percentage of outstanding shares, with 5.8832% or 13.31 million shares worth $11.99 million as of 2024-06-30.
